Companies /Healthcare
Wave Life Sciences Ltd
NASDAQ: WVE Biotechnology
$3.66
▲ $0.21 (+6.08%) today
Markets open · 4:08pm ET

Wave Life Sciences (WVE) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
29%
EPS beat rate
+3.47%
Avg. EPS surprise
Consecutive EPS beats
WVE vs Market · 30-day return after each reportWVES&P 500
−60%0%+60%+120%+10.6%+6.7%Q1 25+17.7%+1.7%Q2 25+137.6%+1.1%Q3 25−56.9%−8.3%Q4 25−12.5%+6.3%Q1 26−14.9%+3.4%Q2 26
−60%0%+60%+120%Q1 25Q3 25Q1 26
WVE EPS Trend · estimate vs actualEstimateActual
$-0.30$-0.20$-0.10$0.00$-0.26$-0.29Q1 25$-0.28$-0.31Q2 25$-0.30$-0.32Q3 25$-0.26$-0.30Q4 25$-0.31$-0.13Q1 26$-0.32$-0.30Q3 26
$-0.30$-0.20$-0.10$0.00Q1 25Q3 25Q1 26
WVE Revenue Trend · estimate vs actualEstimateActual
$0$20.0M$40.0M$11.3M$9.2MQ1 25$9.6M$8.7MQ2 25$10.5M$7.6MQ3 25$15.7M$17.2MQ4 25$7.9M$38.2MQ1 26$4.5M$13.2MQ3 26
$0$20.0M$40.0MQ1 25Q3 25Q1 26

How Often Does Wave Life Sciences Beat Earnings Estimates?

Wave Life Sciences beat EPS estimates in 2 of its last 7 reported quarters, and has beaten 2 quarters in a row.

WVE quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 $-0.30 est. $-0.32 +6.45% $13.2M est. $4.5M +191.92%
Q2 2026 $-0.34 — $2.3M —
Q1 2026 $-0.13 est. $-0.31 +58.51% $38.2M est. $7.9M +382.65%
Q4 2025 $-0.30 est. $-0.26 −13.51% $17.2M est. $15.7M +9.98%
Q3 2025 $-0.32 est. $-0.30 −8.18% $7.6M est. $10.5M −27.73%
Q2 2025 $-0.31 est. $-0.28 −9.00% $8.7M est. $9.6M −9.78%
Q1 2025 $-0.29 est. $-0.26 −13.46% $9.2M est. $11.3M −19.09%

Figures from SEC filings and company reports. Not investment advice.